Skip to content

Elaborate (GCT '21) Raises $10M Seed Round To Modernize Health Diagnostics

plus icon
back
JAN 26 - 2023

Elaborate (GCT '21) Raises $10M Seed Round To Modernize Health Diagnostics

We've made phenomenal progress in the field of health diagnostics, from lab-based tests to wearables, and continue to make progress every day. But our ability to derive real value from them, and drive better health outcomes, is a function of how easily and intuitively we can derive insights, both in the here and now and over time. 

Making progress *here* will empower patients to have a deeper understanding of their own health and drive efficiency in medical practices to help doctors spend more time doing what they love (and coincidentally run more profitable practices). It's no wonder we couldn't be more excited about Elaborate and the amazing work founder Nicole Bocskocsky and team are doing. Congrats to Elaborate on its $10M seed round—read more about its mission to simplify lab results for patients and providers in Fast Company.